Skip to main content

UBS Group AG

Position in PRLD — Prelude Therapeutics Inc

CIK 1610520 ZURICH, V8

Position in PRLD

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,699,187
+$1,478,581 QoQ
Shares Held
318,797
+394.2% QoQ
Ownership
0.399%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 75 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PRLD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. PRLD ranks #223 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PRLD

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,699,187 318,797
2026-03-31 $220,606 64,505
2025-12-31 $5,384 1,857
2025-09-30 $6,005 4,171
2025-06-30 $84,299 104,204
2025-03-31 $73,846 96,156
2024-12-31 $85,921 67,390
2024-09-30 $14,523 7,016
2024-06-30 $41,657 10,934
2024-03-31 $74,204 15,655
2023-12-31 $84,856 19,873
2023-09-30 $22,890 7,408
2023-06-30 $31,013 6,892
2023-03-31 $5,585 980
2022-12-31 $6,263 1,037
2022-09-30 $449 68
2022-06-30 $14,124 2,706
2022-03-31 $1,262 183
2021-12-31 $24,127 1,938
2021-09-30 $1,156,280 37,001
2021-06-30 $216,671 7,568
2021-03-31 $967,817 22,336
2020-12-31 $184,669 2,581
2020-09-30 $42,874 1,423